All Reports Events Blogs Videos
Showing 48 results
  • Provider Compendium
    Nov. 28, 2025

    Everest Group’s Order-to-Cash (O2C) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 16 O2C products and includes insights on the global O2C products market. It examines each product’s features, enhancements, and market adoption…
  • PEAK Matrix®
    Sep. 19, 2025

    Enterprises are leveraging Employer of Record (EoR) solutions to enhance their agility, adaptability, and resilience in hiring workers globally. The shift toward remote work, combined with labor laws’ growing complexities across various regions, has accelerated the…
  • PEAK Matrix®
    April 03, 2025

    Pharmacovigilance (PV) has evolved into a strategic imperative, driven by intensified regulatory scrutiny and an increasing focus on patient safety. Pharmaceutical companies now face a rapidly evolving landscape characterized by rising adverse event volumes, fragmented real-world…
  • PEAK Matrix®
    Sep. 30, 2025

    Enterprises are increasingly turning to modern Order-to-Cash (O2C) products in response to growing cost pressures, tighter regulations, and the need for improved agility. Once viewed as a back-office finance function, O2C is becoming a strategic enabler…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Provider Compendium
    Nov. 19, 2025

    Veeva has become a cornerstone in life sciences digital transformation, offering cloud-based platforms across clinical, regulatory, safety, quality, and commercial functions. As enterprises increasingly adopt Veeva’s vault-based applications and scale global deployments, the demand for specialized…
  • PEAK Matrix®
    Aug. 26, 2026

    Order-to-Cash (O2C) is moving higher on the CFO agenda as enterprises seek to improve cash predictability, support evolving monetization models, and meet rising expectations for seamless stakeholder experiences. These priorities are accelerating demand for O2C products…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • Technology Application Deep Dive
    April 23, 2026

    Digital Therapeutics (DTx) represent a rapidly evolving class of evidence-based interventions that leverage software as a medical device to prevent, manage, or treat medical conditions through behavioral modification, personalized feedback, and continuous data-driven support. Unlike general…
  • R&D Strategic Technology Outlook
    July 31, 2026

    This report examines optically encoded systems as enabling infrastructure for discovery science workflows across chemicals and materials Research and Development (R&D). It explains how optical encoding makes candidate libraries identifiable at scale and turns materials discovery…
  • PEAK Matrix®
    July 31, 2025

    Life sciences enterprises are expanding their use of Veeva Vault across regulated functions, including clinical operations, regulatory information management, quality systems, promotional content management, and CRM. As adoption moves beyond single modules to integrated, cross-Vault deployments,…
  • PEAK Matrix®
    June 03, 2024

    The evolving regulatory landscape poses significant challenges for life sciences enterprises. Enterprises struggle to navigate complex compliance frameworks, stay updated with emerging regulations, and manage diverse geographical requirements, all vital for achieving regulatory compliance and securing…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • PEAK Matrix®
    Nov. 13, 2025

    As cloud costs grow more dynamic and AI use proliferates, FinOps is evolving from cost reporting to a broader operating model that blends granular cost/usage analytics with governance and policy management, AI-powered automation, sustainability/carbon tracking, and…
  • Provider Compendium
    Feb. 08, 2024

    Over the past year, enterprises have faced significant macroeconomic and geopolitical challenges. The potential uncertainties surrounding the implementation of the Inflation Reduction Act (IRA), the escalation in federal interest rates aimed at curbing inflation, and the…
  • PEAK Matrix®
    Sep. 28, 2023

    Over the past one year, enterprises had to overcome a series of macroeconomic and geopolitical challenges. The potential uncertainties with the implementation of the Inflation Regulation Act (IRA), and the rise in federal interest rates to…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Tech Provider Spotlight
    June 02, 2026

    The digital advertising ecosystem is significantly transforming as traditional demand-side platforms evolve into omnichannel advertising platforms. What began as automated tools to buy display advertising has expanded into sophisticated platforms that support audience engagement across connected…
  • Provider Compendium
    June 30, 2023

    Everest Group’s Life Sciences Sales and Marketing Operations – Service Provider Compendium 2023 provides comprehensive and fact-based snapshots of 17 life sciences sales and marketing service providers. It offers a detailed profile of each provider, with…
  • PEAK Matrix®
    March 29, 2023

    The life sciences industry is currently facing several challenges that are significantly impacting drug and device manufacturing costs. In addition to these rising costs, regulatory developments such as the Inflation Reduction Act 2023 and upcoming patent…

Items per page